Sun Pharma Advanced Research Company Ltd has announced a board meeting scheduled for February 09, 2026, to review and approve the unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025. The announcement also mentions a trading window closure for insiders.
Board Meeting Announcement
A meeting of the Board of Directors of Sun Pharma Advanced Research Company Ltd is scheduled for February 09, 2026. The primary agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for Q3 (Oct-Dec) and nine months, ending December 31, 2025.
Trading Window Update
The company has implemented a trading window closure. Effective January 01, 2026, Directors, KMPs, Designated Employees, and Connected Persons are restricted from trading shares. The trading window will remain closed until 48 hours after the declaration and submission of the Financial Results to the Stock Exchanges.
Source: BSE
